Lipid Peroxidation in Ferroptosis and Association with Nonalcoholic Fatty Liver Disease

被引:7
|
作者
Zhao, Shengnan [1 ]
Guo, Yan [1 ]
Yin, Xunzhe [2 ]
机构
[1] Changchun Univ Chinese Med, Sch Clin Med, Changchun 130117, Jilin, Peoples R China
[2] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2023年 / 28卷 / 12期
关键词
ferroptosis; lipid peroxidation; nonalcoholic fatty liver disease; ferritinophagy; CANCER CELLS; TRAUMATIC BRAIN; AUTOPHAGY; MECHANISMS; INHIBITION; STRESS; DEATH; STEATOHEPATITIS; ACTIVATION; APOPTOSIS;
D O I
10.31083/j.fbl2812332
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nonalcoholic fatty liver disease (NAFLD) constitutes a commonly diagnosed liver pathology with perturbed lipid metabolism, which is mainly caused by excessive accumulation of fat in hepatocytes by various pathogenic factors. Currently, there are no effective drug treatments for NAFLD. Ferroptosis represents a novel form of programmed cell death depending on iron, which is driven by large cellular amounts of reactive oxygen species (ROS) and lipid peroxides. Ferroptosis plays critical regulatory roles in the pathogenesis of NAFLD, and overaccumulation of Fe2+ contributes to lipid peroxidation, which subsequently aggravates NAFLD. Therefore, ferroptosis suppression might constitute an important target for NAFLD treatment. This article reviews the discovery, production pathways, and defense mechanisms of ferroptosis, and explores its association with NAFLD. This may provide new reference targets and strategies for the development of NAFLD drugs from the perspective of ferroptosis.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Lipid mediators of liver injury in nonalcoholic fatty liver disease
    Liangpunsakul, Suthat
    Chalasani, Naga
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2019, 316 (01): : G75 - G81
  • [22] Polyunsaturated Fatty Acids Drive Lipid Peroxidation during Ferroptosis
    Mortensen, Michael S. S.
    Ruiz, Jimena
    Watts, Jennifer L. L.
    CELLS, 2023, 12 (05)
  • [23] Allostasis in Nonalcoholic Fatty Liver Disease: Implications for Risk Assessment
    Baffy, Gyoergy
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (02) : 302 - 308
  • [24] Osteopontin acts as a negative regulator of autophagy accelerating lipid accumulation during the development of nonalcoholic fatty liver disease
    Tang, Min
    Jiang, Yan
    Jia, Haoyu
    Patpur, Bhuvanesh Kinish
    Yang, Bo
    Li, Jing
    Yang, Changqing
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2020, 48 (01) : 159 - 168
  • [25] Serum Lipid Abnormalities and Nonalcoholic Fatty Liver Disease in Adult Males
    Peng, Keping
    Mo, Zengnan
    Tian, Guixiang
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2017, 353 (03) : 236 - 241
  • [26] Porphyromonas gingivalis is a risk factor for the development of nonalcoholic fatty liver disease via ferroptosis
    Yao, Chao
    Lan, Dongmei
    Li, Xue
    Wang, Yan
    Qi, Shengcai
    Liu, Yuehua
    MICROBES AND INFECTION, 2023, 25 (1-2)
  • [27] Differential effects of reticulophagy and mitophagy on nonalcoholic fatty liver disease
    Pang, Lijun
    Liu, Kai
    Liu, Daojie
    Lv, Fudong
    Zang, Yunjin
    Xie, Fang
    Yin, Jiming
    Shi, Ying
    Wang, Yanjun
    Chen, Dexi
    CELL DEATH & DISEASE, 2018, 9
  • [28] Nonalcoholic Fatty Liver Disease
    Law, Kathryn
    Brunt, Elizabeth M.
    CLINICS IN LIVER DISEASE, 2010, 14 (04) : 591 - +
  • [29] Metformin improves nonalcoholic fatty liver disease in db/db mice by inhibiting ferroptosis
    Zhang, Teng
    Wang, Meng-Yan
    Wang, Guo-Dong
    Lv, Qiu-Yue
    Huang, Yu-Qian
    Zhang, Peng
    Wang, Wen
    Zhang, Yan
    Bai, Ya-Ping
    Guo, Li-Qun
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 966
  • [30] Systemic redox imbalance in patients with nonalcoholic fatty liver disease
    Asghari, Somayyeh
    Hamedi-Shahraki, Soudabeh
    Amirkhizi, Farshad
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2020, 50 (04)